Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Etiologic and Effectiveness Research to Address Polysubstance Impaired Driving
The purpose of this funding is to support etiologic and effectiveness research on driving while polysubstance impaired.
Specifically, research is solicited to identify risk and protective factors associated with polysubstance impaired driving and its associated deaths and injuries, or to identify
effective interventions to prevent polysubstance impaired driving and its associated deaths and injuries.
Polysubstance impaired driving includes driving while impaired by alcohol plus at least one other drug, such as marijuana or opioids.
Research Priority #1 is to conduct etiologic research to inform our understanding of the characteristics of and risk and protective factors associated with impaired driving when alcohol plus other drugs (such as marijuana or prescription or illicit opioids) are involved.
Research Priority #2 is to conduct effectiveness research to evaluate interventions most effective at preventing driving while impaired by alcohol plus other drugs (such as marijuana or prescription or illicit opioids).
Specifically, research is solicited to identify risk and protective factors associated with polysubstance impaired driving and its associated deaths and injuries, or to identify
effective interventions to prevent polysubstance impaired driving and its associated deaths and injuries.
Polysubstance impaired driving includes driving while impaired by alcohol plus at least one other drug, such as marijuana or opioids.
Research Priority #1 is to conduct etiologic research to inform our understanding of the characteristics of and risk and protective factors associated with impaired driving when alcohol plus other drugs (such as marijuana or prescription or illicit opioids) are involved.
Research Priority #2 is to conduct effectiveness research to evaluate interventions most effective at preventing driving while impaired by alcohol plus other drugs (such as marijuana or prescription or illicit opioids).
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $4,200,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $4,200,000
Who's Eligible
Obtain Full Opportunity Text:
Please click on Full Announcement at the top of this page to access the document
Additional Information of Eligibility:
Foreign Organizations are not eligible to apply.
Foreign components of U. S. Organizations are not eligible to apply.
Full Opportunity Web Address:
www.grants.gov
Contact:
Agency Email Description:
Grants Policy
Agency Email:
Date Posted:
2018-12-12
Application Due Date:
Archive Date:
2019-04-14
Follow @topgovtgrant
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Nonprofit Jobs in Alabama
Fundraising & Development Jobs
Social Services Employment
Substance Abuse Jobs
Program Director Jobs
Social Services Jobs
Learn How to Identify and Avoid Grant Scams
